KRThe Kroger Co.
The Kroger Co. sells groceries, fuel, and pharmacy services to millions of households across the U.S. Its next catalyst is Nov 6, 2026 — Q3 2026 Earnings Release & 2026–27 Margin Outlook, which will test its ability to stabilize margins after a recent 0.4% YoY revenue growth and 0.6% net margin. (No matching source found for this event.)
- Kroger operates 3,800 stores and 1,200 pharmacies, with a 2.91x debt-to-equity ratio.
- The company’s TTM net margin is 0.6%, with $148.54B in revenue and $833M in net income for the 2026-08-15 period end.
- Shareholders’ equity stands at $5.93B, with diluted EPS of $1.05.
The Read
8% on strong Q4 2025 earnings and 2026 guidance, then rallied 18%.
The schedule
- Fri15Jan
Kroger’s post-holiday 2026 trading update or early commentary on seasonal performance, including digital penetration, loyalty program engagement, and private-label share gains. Strong traffic and robust digital growth could take KR toward $64.00, while evidence of consumer trade-down away from higher-margin categories or slowing online momentum could move shares toward $64.00.
- Tue4May
Kroger’s Q1 2027 results and initial full-year 2027 guidance. Clear earnings visibility, disciplined capex, and steady free cash flow conversion could move KR toward $61.00, while a guidance reset on margins or comps could drag the stock toward $61.00.
- Fri6Aug
Kroger’s Q2 2027 earnings, with investor focus on the profitability of its digital and delivery operations and any update on automation or micro-fulfillment initiatives. Demonstrated operating leverage in e-commerce could move the stock toward $55.00, while weaker unit economics or slower digital growth could push shares toward $55.00.
- Fri5Nov
- Fri4Feb
Past
- Tue20Oct
Kroger’s Q3 2026 earnings release and margin outlook for the holiday season and early 2027. If KR demonstrates continued traffic resilience, effective price investments, and early signs of margin stabilization despite GLP-1 and competitive pressures, the stock could move toward $59.50. A weaker same-store sales print or renewed compression in gross margin could drive shares toward $59.50.
- Thu10Sep
Key late-2026 regulatory update on Kroger’s proposed Albertsons merger, including any revised store divestiture package or litigation path with the FTC. A clearer remedy framework and timeline could re-rate KR toward $63.00, while signals of a prolonged legal fight or higher required divestitures could push the stock toward $63.00.
- Thu18Jun
Actual outcome: Mixed · $55.91 at outcome
Kroger's Q1 earnings met EPS estimates and beat on revenue, but shares initially slid 8% as cost pressures and price investments weighed on margins. However, the stock recovered most of its losses by the outcome date, aided by an 11% dividend increase and an expanded rewards program, resulting in a relatively flat overall price reaction.
Kroger's Q1 earnings met EPS estimates and beat on revenue, but shares initially slid 8% as cost pressures and price investments weighed on margins. However, the stock recovered most of its losses by the outcome date, aided by an 11% dividend increase and an expanded rewards program, resulting in a relatively flat overall price reaction.
- Mon9Mar
Actual outcome: Bear · $66.79 at outcome
The stock fell 9.0% following the event date, trending toward the bear floor. While Kroger announced the addition of Zepbound to its retail pharmacies and maintained its quarterly dividend, shares were weighed down by broader macroeconomic headwinds, including potential global supply chain disruptions and retail price impacts stemming from geopolitical conflict, with no positive regulatory breakthrough on the Albertsons merger to offset the pressure.
The stock fell 9.0% following the event date, trending toward the bear floor. While Kroger announced the addition of Zepbound to its retail pharmacies and maintained its quarterly dividend, shares were weighed down by broader macroeconomic headwinds, including potential global supply chain disruptions and retail price impacts stemming from geopolitical conflict, with no positive regulatory breakthrough on the Albertsons merger to offset the pressure.
- Thu5Mar
Actual outcome: Bull · $73.37 at outcome
Kroger met Q1 2026 earnings expectations with an EPS of $1.37, successfully addressing intense market focus on private-label volume growth and margin defense against supply chain pressures. This solid fundamental execution reassured investors, driving the stock to close at $73.37, well above the $65.50 bull target.
Kroger met Q1 2026 earnings expectations with an EPS of $1.37, successfully addressing intense market focus on private-label volume growth and margin defense against supply chain pressures. This solid fundamental execution reassured investors, driving the stock to close at $73.37, well above the $65.50 bull target.
- Thu29Jan
Actual outcome: Bull · $73.39 at outcome
The catalyst resulted in a clear BULL outcome, as the stock price soared to $70.86, significantly clearing the $64.50 bull target. This strong move implies that Kroger successfully delivered Q4 results and 2026 guidance that confirmed a return to stable profitability and robust same-store sales growth. The positive outlook successfully alleviated market concerns stemming from the prior quarter's large net loss, driving the sustained rally.
The catalyst resulted in a clear BULL outcome, as the stock price soared to $70.86, significantly clearing the $64.50 bull target. This strong move implies that Kroger successfully delivered Q4 results and 2026 guidance that confirmed a return to stable profitability and robust same-store sales growth. The positive outlook successfully alleviated market concerns stemming from the prior quarter's large net loss, driving the sustained rally.
Scouting Reports

Brent Breaks $95: Testing the E&P Capital Discipline Pledge
Nov 5, 2026
Broad markets celebrated the midterm election gridlock on Wednesday, sending the Dow up 1,500 points on the assumption that a divided Washington means a pause on transformative economic policy. But th
Read more →
Weekly Playbook: Pricing the Healthcare Gauntlet (ABEO, LFVN, KROS)
Oct 5, 2026
The healthcare and biotech sectors are defined by their bottlenecks. Whether a company is waiting on federal guidance or fighting to clear a clinical hurdle, the market brutally penalizes any friction
Read more →
The Pricing Wall: How Walmart and Kroger Are Engineering Margins
Sep 17, 2026
Consumer staples have enjoyed a multi-year cheat code: hiking prices to mask shrinking volumes. That free pass just expired.
Read more →